Stanley Lapidus, Director at Lucid Diagnostics Inc. (LUCD), sold 3,917 shares at $1.44 ($6K) on 2023-09-20, disclosed to the SEC on 2023-09-27.
Scheduled sale ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.44 | 412 | $593 | 10.5% |
| 2 | $1.45 | 3,405 | $5K | 87.0% |
| 3 | $1.44 | 100 | $144 | 2.5% |
| Total | $1.45 avg | 3,917 | $6K | 100% |
| Filing → |
| TTOO | SELL | 2019-06-13 | $13K | — | Filing → |
| TTOO | SELL | 2018-11-08 | $32K | — | Filing → |
| TTOO | SELL | 2018-06-05 | $53K | — | Filing → |